Firstly Norway is the biggest salmon aquaculture producer in the world
Getting the approval from Norway is significant for Aquaterra as it means big dollars to Nufarm. Unfortunately Nufarm has not communicated clearly on the revenue numbers. So the only way to look at is the most recent investor slides to get a good idea of the market opportunity.
Let us assume that most of the Aquaterra sales are coming from Chile and a minority from North America.
From the 1st chart on Salmon production, there is obviously a large opportunity to capture some meaningful revenue when comparing Chile and North America (USA and Canada) with Norway.
With the drive to replace smaller fish feed (ie: sardines etc.) with something more sustainable and easier to produce, Nufarm could be well placed in generating lots of revenue, particularly in Norway.
Yes it is a recession and Yes people can forgo nutrition for days. But Aquaterra is a new market opportunity that could displace normal sources of fish feed for aquaculture.
And also rains appear to have returned to the American wheatbelt. Maybe Nufarm can start runninig down their inventory in USA
The selling is well overdone. Aquaterra could potentially the peaks and troughs of other areas and give Nufarm some much needed consistency in earnings.
Topped up on the morning dip before the late buying in the afternoon.
[held]